熱門詞： 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
熱門詞： 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
CeMines 愛沙尼亞CeMines
生命科學(xué)和生物技術(shù)領(lǐng)域的新專家，專業(yè)提供分子研究工具、診斷產(chǎn)品、先進(jìn)療法（如將基因功能研究應(yīng)用于癌癥療法）
CeMines was founded in 2000 by Richard Cavalli, Dr. Toomas Neuman, Ph.D. and Dr. Kaia Palm, Ph.D. to develop cancer diagnostics using two methods: auto-antibody and splice variants.
Our focus is on the early, and accurate detection of Cancer within the human body with an initial product focus on Lung Cancer.
We are creating molecular diagnostics for cancer based on a simple blood test. This method analyzes a drop of blood for the presence of antibodies your body produces to fight cancer. Our approach identifies cancer before it spreads and provides a preventative measure for “at-risk” populations.
Our R&D is focused on diagnostic tests for lung, breast, gastrointestinal and leukemia. In addition to cancer, however, our science has applications for Immune disorders such as Hepatitis C, HIV and Rheumatoid Arthritis. We are also extending our methods to transplant donor matching applications.
CeMines Corporate Headquarters is in Golden, Colorado and our Scientific Laboratories are in Tallinn, Estonia.
知識(shí)產(chǎn)權(quán)侵權(quán)投訴：不生產(chǎn)任何產(chǎn)品所有產(chǎn)品均來自產(chǎn)品的生產(chǎn)廠商、代理商、經(jīng)銷商，如有侵權(quán)請(qǐng)聯(lián)系：400-006-7520 ，我們會(huì)在第一時(shí)間處理
本網(wǎng)站所有產(chǎn)品與藥品無關(guān)
滬公網(wǎng)安備31011502016460號(hào)
